查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519456

2024-2032年按藥物類別、適應症（胃食道逆流或胃灼熱、便秘、腹瀉、暈動病等）、最終使用者和地區分類的胃腸道非處方藥市場

Gastrointestinal OTC Drugs Market by Drug Class, Indication (Gastroesophageal Reflux Disease or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球胃腸道非處方藥市場規模達420億美元。胃腸道疾病盛行率的上升、大眾對消化健康的認知不斷提高以及先進配方的最新開發是推動市場的一些關鍵因素。

胃腸道非處方藥 (OTC) 是指緩解胃腸道症狀並促進整體消化健康的非處方藥。它包括瀉藥、制酸劑、H2 阻斷劑、質子幫浦抑制劑 (PPI)、止吐藥、腸道抗發炎藥和止瀉藥。胃腸道非處方藥廣泛用於治療消化不良、便秘、胃灼熱、腹瀉、暈動病、胃酸逆流、噁心、腸躁症（IBS）和腹痛。它是一種經濟高效、方便且易於使用的產品，可立即緩解症狀、提高患者舒適度並允許自我管理。胃腸道非處方藥也有助於改善腸道健康，恢復有益細菌，預防未來的併發症，並最大限度地減輕各種症狀的嚴重程度，例如疼痛、腹脹、腹部不適和嘔吐。

胃腸道非處方藥市場趨勢：

由於久坐的生活方式和不健康的飲食習慣導致胃腸道疾病的盛行率不斷上升，這是推動市場成長的關鍵因素之一。胃腸道非處方藥廣泛用於治療感染、消化不良、急性腹瀉、胃灼熱、胃食道逆流（GERD）、便秘、腹脹和孕吐。此外，由於大眾對消化健康的認知不斷增強，用於改善消化、促進腸道健康、確保營養物質適當分解和吸收的產品應用不斷增加，也為市場成長提供了動力。與此一致的是，自我照護和消費者賦權以管理福祉和預防未來健康併發症的新興趨勢正在成為另一個成長誘導因素。此外，最近開發的先進製劑，如發泡錠、液體、混懸劑、薄膜條和咀嚼產品，增強了藥物的有效性，增加了吸收，並減少了給藥頻率，對市場成長產生了積極影響。除此之外，泡殼包裝、可重複密封袋和單劑量包裝等方便且適合旅行的包裝的引入正在推動市場成長。除此之外，消費者對非侵入性治療的日益偏好正在促進解決常見消化問題並提供即時緩解的產品需求。此外，一些製造商透過電視廣告、社群媒體、有影響力的行銷和名人代言積極的促銷和品牌活動正在加強市場的成長。其他因素，包括老年人口的增加、消費者支出能力的增強以及電子商務平台上產品的便捷獲取，預計將推動市場成長。

本報告回答的關鍵問題

  • 全球胃腸道非處方藥市場有多大？
  • 2024-2032年全球胃腸道非處方藥市場的預期成長率是多少？
  • 推動全球胃腸道非處方藥市場的關鍵因素是什麼？
  • COVID-19對全球胃腸道非處方藥市場有何影響？
  • 全球胃腸道非處方藥市場的重點區域有哪些？
  • 全球胃腸道非處方藥市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球胃腸道非處方藥市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依藥物類別

  • 瀉藥
    • 市場走向
    • 市場預測
  • 胃腸癌治療
    • 市場走向
    • 市場預測
  • 胃酸減少劑
    • 市場走向
    • 市場預測
  • 止瀉
    • 市場走向
    • 市場預測
  • 質子幫浦抑制劑
    • 市場走向
    • 市場預測
  • H2抑制劑
    • 市場走向
    • 市場預測
  • 胃酸中和劑
    • 市場走向
    • 市場預測
  • 腸道消炎
    • 市場走向
    • 市場預測
  • 止吐藥
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依跡象

  • 胃食道逆流症 (GERD) 或胃灼熱
    • 市場走向
    • 市場預測
  • 便秘
    • 市場走向
    • 市場預測
  • 腹瀉
    • 市場走向
    • 市場預測
  • 暈動症
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boehringer Ingelheim GmbH
    • Johnson & Johnson
    • Prestige Consumer Healthcare Inc.
    • Purdue Pharma LP
    • Sanofi
    • Zydus Lifesciences Limited
Product Code: SR112024A7781

The global gastrointestinal OTC drugs market size reached US$ 42.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 60.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.

Gastrointestinal over-the-counter (OTC) drugs refer to non-prescription medications that alleviate gastrointestinal symptoms and promote overall digestive wellness. It includes laxatives, antacids, H2 blockers, proton pump inhibitors (PPIs), anti-emetics, bowel anti-inflammatory, and anti-diarrheal medications. Gastrointestinal OTC drugs are widely used to treat indigestion, constipation, heartburn, diarrhea, motion sickness, acid reflux, nausea, irritable bowel syndrome (IBS), and abdominal pain. It is a cost-effective, convenient, and easily accessible product that provides immediate relief, enhances patient comfort, and allows self-management. Gastrointestinal OTC drugs also aid in improving gut health, restoring beneficial bacteria, preventing future complications, and minimizing the severity of various symptoms, such as pain, bloating, abdominal discomfort, and vomiting.

Gastrointestinal OTC Drugs Market Trends:

The rising prevalence of gastrointestinal disorders due to sedentary lifestyles and unhealthy eating habits is one of the key factors providing a thrust to the market growth. Gastrointestinal OTC drugs are widely used to treat infections, dyspepsia, acute diarrhea, heartburn, gastroesophageal reflux disease (GERD), constipation, bloating, and morning sickness. Furthermore, the increasing product applications to improve digestion, promote gut health, and ensure proper breakdown and absorption of nutrients, owing to the growing awareness among the masses regarding digestive health, is providing an impetus to the market growth. In line with this, the emerging trends of self-care and consumer empowerment to manage well-being and prevent future health complications are acting as another growth-inducing factor. Additionally, the recent development of advanced formulations, such as effervescent tablets, liquids, suspensions, film strips, and chewable products, which enhances the effectiveness of the drugs, increases absorption, and reduces the frequency of dosing, is positively influencing the market growth. Besides this, the introduction of convenient and travel-friendly packaging, such as blister packs, resealable pouches, and single-dose packets, is propelling the market growth. Apart from this, the rising consumer preference for non-invasive treatments is facilitating product demand to manage common digestive issues and provide immediate relief. Moreover, aggressive promotional and branding campaigns by several manufacturers through television (TV) commercials, social media, influencer marketing, and celebrity endorsement is strengthening the market growth. Other factors, including the rising geriatric populations, increasing expenditure capacities of consumers, and easy availability of products across e-commerce platforms, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global gastrointestinal OTC drugs market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on drug class, indication, and end user.

Drug Class Insights:

Laxatives

Gastrointestinal Cancer Treatments

Gastric Acid Reducers

Anti-Diarrheal

Proton Pump Inhibitors

H2 Inhibitors

Gastric Acid Neutralizers

Bowel Anti-Inflammatory

Anti-Emetics

The report has provided a detailed breakup and analysis of the gastrointestinal OTC drugs market based on the drug class. This includes laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti-diarrheal, proton pump inhibitors, H2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory, and anti-emetics.

Indication Insights:

Gastroesophageal Reflux Disease (GERD) or Heartburn

Constipation

Diarrhea

Motion Sickness

Others

A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the indication has also been provided in the report. This includes gastroesophageal reflux disease (GERD) or heartburn, constipation, diarrhea, motion sickness, and others.

End User Insights:

Hospitals

Clinics

Others

A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the end user has also been provided in the report. This includes hospitals, clinics, and others.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for gastrointestinal OTC drugs. Some of the factors driving the North America gastrointestinal OTC drugs market included the rising prevalence of gastrointestinal disorders, increasing awareness among the masses, and various product innovations.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global gastrointestinal OTC drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim GmbH, Johnson & Johnson, Prestige Consumer Healthcare Inc., Purdue Pharma L.P, Sanofi, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global gastrointestinal OTC drugs market?
  • 2. What is the expected growth rate of the global gastrointestinal OTC drugs market during 2024-2032?
  • 3. What are the key factors driving the global gastrointestinal OTC drugs market?
  • 4. What has been the impact of COVID-19 on the global gastrointestinal OTC drugs market?
  • 5. What are the key regions in the global gastrointestinal OTC drugs market?
  • 6. Who are the key players/companies in the global gastrointestinal OTC drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gastrointestinal OTC Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Laxatives
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gastrointestinal Cancer Treatments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gastric Acid Reducers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Anti-Diarrheal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Proton Pump Inhibitors
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 H2 Inhibitors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Gastric Acid Neutralizers
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Bowel Anti-Inflammatory
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Anti-Emetics
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Gastroesophageal Reflux Disease (GERD) or Heartburn
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Constipation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Motion Sickness
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Prestige Consumer Healthcare Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Purdue Pharma L.P
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Sanofi
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Zydus Lifesciences Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Gastrointestinal OTC Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Gastrointestinal OTC Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Gastrointestinal OTC Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Gastrointestinal OTC Drugs Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Gastrointestinal OTC Drugs Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Gastrointestinal OTC Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Gastrointestinal OTC Drugs (Laxatives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Gastrointestinal OTC Drugs (Laxatives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Gastrointestinal OTC Drugs (Constipation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Gastrointestinal OTC Drugs (Constipation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Gastrointestinal OTC Drugs (Diarrhea) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Gastrointestinal OTC Drugs (Diarrhea) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Gastrointestinal OTC Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Gastrointestinal OTC Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Gastrointestinal OTC Drugs (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Gastrointestinal OTC Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Gastrointestinal OTC Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Gastrointestinal OTC Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Gastrointestinal OTC Drugs (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Gastrointestinal OTC Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Gastrointestinal OTC Drugs Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Gastrointestinal OTC Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Gastrointestinal OTC Drugs Industry: Value Chain Analysis
  • Figure 91: Global: Gastrointestinal OTC Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gastrointestinal OTC Drugs Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Gastrointestinal OTC Drugs Market: Competitive Structure
  • Table 7: Global: Gastrointestinal OTC Drugs Market: Key Players